Page 5 of Biocon

Biocon Biologics, Biosimilars, Yoshindo Inc, Ustekinumab, bUstekinumab, health news, pharma news,

Biocon’s net profit rises 71 percent to Rs 144.4 crore in first quarter

In the corresponding quarter last year, the company posted a net profit of Rs 84.4 crore.

Updated: July 28, 2022 18:27 IST

Roshni Nadar India’s richest woman 2nd year in a row; Nykaa’s Falguni Nayar overtakes Kiran Mazumdar-Shaw

Roshni Nadar Malhotra, the chairperson of HCL Technologies, has retained the tag of the richest woman in India for the…

July 27, 2022 16:32 IST

Biocon Biologics receives EU GMP certification for its new biologics manufacturing facility in Bengaluru

According to the company’s press statement, the facility, spread across 340,000 square feet, will enhance the capabilities to manufacture drug…

July 5, 2022 19:11 IST

stocks to watch, stocks in focus, stocks in news, reliance ril

Reliance, Infosys, LIC, Biocon, Indian Oil, GR Infraprojects stocks in focus on monthly F&O expiry

Indian equity markets are likely to extend losses on Thursday as SGX Nifty signalled at a gap-down open for benchmark…

Updated: June 30, 2022 08:24 IST

Bajaj Finserv, Biocon among 39 stocks to hit 52-week low on BSE, 64 scrips at new highs

After a dismal start, benchmark indices recovered most of their losses on Wednesday as metals and some energy counters gathered…

June 29, 2022 12:52 IST

Expect regulatory nods for deal with Serum and Viatris to come by H2: Kiran Mazumdar-Shaw, chairperson, Biocon and Biocon Biologics

The vaccines alliance with Serum and our continued investment in R&D, adding products to our portfolio, opens up new growth…

May 4, 2022 06:00 IST

Biocon Biologics gets European Medicines Agency’s backing for Inpremzia

Inpremzia has been developed by Celerity Pharmaceuticals LLC using Biocon Biologics’ biosimilar insulin drug substance, Biocon Ltd said in a…

April 1, 2022 15:35 IST

University of Glasgow Names Research Centre After John Shaw and Kiran Mazumdar-Shaw

Mr John Shaw, who is a Glasgow University graduate, along with his wife Ms Kiran Mazumdar- Shaw had gifted $7.5…

March 29, 2022 16:00 IST

Expect Biocon to become fully integrated biosimilars firm post Viatris buy: Kiran Mazumdar-Shaw

Post the closure of the Viatris’ deal, Biocon Biologics will realise the full revenue and profits from its products, which…

March 24, 2022 03:50 IST

FE Pharma Summit, Sun Pharmaceutical, Zydus Cadila, Glenmark Pharmaceuticals, Biocon, DCGI

FE Pharma Summit to see industry titans swap ideas on steps to counter prickly challenges

The two day FE Pharma Summit 2022 is also an attempt to leverage the ability of the Indian pharma stakeholders…

Updated: March 23, 2022 15:05 IST

BBL (a subsidiary of BIOS) will acquire Viatris’ Biosimilar business to create a vertically integrated company in the Biologics segment.

Biocon Rating ‘Neutral’; Deal completes value chain in biologics

Valuation of Viatris’ biz is expensive; FY23/24e EPS up 3.4/15% with TP at Rs 385; ‘Neutral’ retained given limited upside

March 5, 2022 03:30 IST

Biocon share price falls 12% after deal with Viatris; should you buy, hold or sell? Here’s what brokerages say

Biocon’s recent acquisition of Viatris’ biosimilar assets offers significant long-term growth opportunities. However, a substantially higher debt to fund the…

March 2, 2022 11:18 IST

Cash-and-stock deal: Biocon Biologics acquires Viatris for $3.33 billion

Biocon shares posted their biggest single-day fall since August 2015.

March 1, 2022 04:45 IST

Biocon Biologics, Viatris, Biosimilars, definitive agreement, CCPS, Serum Institute Life Sciences, Kiran Mazumdar Shaw

Biocon Biologics to acquire Viatris’ Biosimilars for up to USD 3.3 billion in stock and cash

The acquisition of biosimilars assets of Viatris significantly strengthens BBL’s position in providing affordable access to patients through its portfolio…

Updated: February 28, 2022 11:31 IST

Biocon Biologics buys Viatris’ biosimilars business in $3.3 bln deal; Mazumdar-Shaw to continue as chairperson

Kiran Mazumdar-Shaw, founder and executive chairperson of Biocon, said the deal will fast-track the company’s journey to build Biocon into…

February 28, 2022 10:57 IST

Biocon chairperson Kiran Mazumdar-Shaw calls for incentive scheme for research

Mazumdar-Shaw further said as the government has come up with incentives for production, it should also come up with incentives…

Updated: February 9, 2022 22:29 IST

Under PLI scheme, Biocon will receive up to Rs 250-crore financial incentives over next six years: Siddharth Mittal

Biocon is today one of the largest manufacturers of statins and immunosuppressants in the world.

February 1, 2022 06:10 IST

Infosys, Indian Oil, Adani Green, Bosch, stocks in focus

Infosys, Indian Oil, Adani Green, Bosch, HPCL, Biocon, JK Lakshmi Cement, Relaxo stocks in focus

Domestic equity market benchmarks BSE Sensex and Nifty 50 were eyeing a positive start on Thursday after markets took a…

May 20, 2021 08:09 IST

Related News

From H-1B to green card: Follow the journey of an Indian entrepreneur to $3.7 billion

Indian techie overcomes H-1B challenges, gets green card, quits job, and achieves $3.7 billion success

Four big companies have now stopped sponsoring H-1B visas. Here is the full list

EB-5 fees, EB-5 filing fees cut, EB-5 visa, USCIS EB-5 rule, DHS EB-5 rule, Form I-526 fee reduction, Form I-829 petition, EB-5 investor program, EB-5 technology fee, EB-5 program changes

US cuts EB-5 fees for foreign investors seeking employment-based green cards

Jefferies buy recommendations, Jefferies stock picks India

3 ‘Buy’ recommendations by Jefferies, with up to 34% upside potential

gold price, silver price, gold market, silver market, gold price today, silver price today, silver investment, buy gold, buy silver, gold price fall, silver price fall, gold price prediction, silver price prediction,

Gold, Silver Crash Sparks Investor Debate: Technical correction or end of the rally?

UP Minister Baby escapes collision on Agra-Lucknow Expressway as truck tyre bursts

India News14 min ago

Uttar Pradesh’s Minister for Women Welfare and Child Development, Baby Rani Maurya, narrowly escaped a road accident on the Agra-Lucknow Expressway. Her driver’s quick reflexes prevented a major accident after their car collided with a truck. Maurya has instructed authorities to review safety measures on the expressway. In a separate incident, three people were killed.

View all shorts